Cargando…
Homologous recombination repair gene mutations show no survival benefits in Chinese high-grade serous ovarian cancer patients
BACKGROUND: The purpose of our study was to identify germline and somatic homologous recombination repair (HRR) pathway gene mutations and their clinical-prognostic impact in Chinese high-grade serous ovarian cancer (HGSC) patients. METHODS: We applied next-generation sequencing (NGS) in consecutive...
Autores principales: | Feng, Zheng, Wen, Hao, Ju, Xingzhu, Bi, Rui, Chen, Xiaojun, Yang, Wentao, Wu, Xiaohua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033363/ https://www.ncbi.nlm.nih.gov/pubmed/33842585 http://dx.doi.org/10.21037/atm-20-5136 |
Ejemplares similares
-
Homologous recombination deficiency status predicts response to platinum-based chemotherapy in Chinese patients with high-grade serous ovarian carcinoma
por: Feng, Zheng, et al.
Publicado: (2023) -
Preoperative Neutrophil-to-Lymphocyte Ratio as a Predictive and Prognostic Factor for High-Grade Serous Ovarian Cancer
por: Feng, Zheng, et al.
Publicado: (2016) -
The preoperative prognostic nutritional index is a predictive and prognostic factor of high-grade serous ovarian cancer
por: Feng, Zheng, et al.
Publicado: (2018) -
Hormone receptor expression profiles differ between primary and recurrent high-grade serous ovarian cancers
por: Feng, Zheng, et al.
Publicado: (2017) -
A clinically applicable molecular classification for high-grade serous ovarian cancer based on hormone receptor expression
por: Feng, Zheng, et al.
Publicado: (2016)